Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

Clinical trial NCT06734832 · RECRUITING

Trial details

NCT number: NCT06734832
Sponsor: Sinovac Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hand, Foot, and Mouth Disease（HFMD)

Start date: 2024-12-13
Primary completion: 2025-11-30
Enrollment: 8000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.